Riboswitches are structures that form in mRNA and regulate gene expression in bacteria. Unlike other known RNA regulatory structures, they are directly bound by small ligands. The mechanism by which gene expression is regulated involves the formation of alternative structures that, in the repressing conformation, cause premature termination of transcription or inhibition of translation initiation. Riboswitches regulate several metabolic pathways including the biosynthesis of vitamins (e.g. riboflavin, thiamin and cobalamin) and the metabolism of methionine, lysine and purines. Candidate riboswitches have also been observed in archaea and eukaryotes. The taxonomic diversity of genomes containing riboswitches and the diversity of molecular mechanisms of regulation, in addition to the fact that direct interaction of riboswitches with their effectors does not require additional factors, suggest that riboswitches represent one of the oldest regulatory systems.The regulation of gene expression in bacteria involving a choice between two alternative structures in the RNA transcript is a well-known phenomenon [1,2]. In most cases one of the alternative structures (i.e. the repressing conformation) contains a terminator of transcription or a paired region covering the translation initiation site, whereas in the second alternative structure (i.e. the nonrepressing conformation) this regulatory element of the secondary structure is destroyed and the gene(s) are expressed. Which one of these structures will fold depends on the concentration of the target metabolite (e.g. a product of the regulated pathway or a compound to be catabolized) sensed via an intermediate molecule [3]. For example, a regulator protein might bind to one of the structures in the presence of an effector (e.g. TRAP protein [4] or antiterminators of the BglG/SacY family [5]) or uncharged tRNA might stabilize one of the conformations (e.g. T-boxes [6]). In classic attenuators of Escherichia coli, the formation of alternative structures depends on the relative rate of translation by the ribosome (as determined by the concentration of charged tRNAs in attenuators of amino acid operons [1]) and transcription by the RNA polymerase (correlated with the concentration of available nucleotide triphosphates, for example, in the pyrBI operon [7]).However, recently it was demonstrated that small molecules can bind directly regulatory mRNA structures, called riboswitches [8]. Riboswitches were shown to regulate several metabolic pathways involved in the biosynthesis of vitamins, amino acids and purines. Although the history behind these findings is diverse, common patterns are emerging in all systems that have been studied.
Regulation by riboswitchesRepression of the riboflavin operon of Bacillus subtilis was initially thought to be due to a regulator protein. However, two candidates for this role, RibC and RibR, which were identified genetically, were later shown to regulate the rib operon indirectly. Both proteins have flavokinase activity and thus decrease the con...